Observational analysis improves megakaryocyte function and mitochondrial activity in acute myeloid leukemia, indicating potential for treating thrombocytopenia.
Key Points
Mitochondrial ROS levels improve in megakaryocytes when treated with Paquinimod during acute myeloid leukemia.
RNA-seq analysis shows distinct signaling pathways involved in megakaryocyte function across AML patients.
Electron microscopy reveals significant mitochondrial morphological changes and reduced content in megakaryocytes of AML models.
Combination therapy of Paquinimod and cytarabine may alleviate thrombocytopenia by enhancing megakaryocyte function.